Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

  • Filter By:
  • Molecular Testing as the Basis for Targeted Therapies in NSCLC
  • CME
  • Molecular Testing as the Basis for Targeted Therapies in NSCLC

  • March 17, 2014
  • NSCLC comprises approximately 85% of all lung cancer cases. NSCLC histologies are primarily adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Certain genetic alterations have allowed… More »
  • Credit Type(s): CME | Credit: 1
  • Improve communication with iNHL patients
  • Top 10 Questions in Indolent B-cell non-Hodgkin Lymphoma

  • February 5, 2014
  • Learn about what hematologists/oncologists should be asking their patients with indolent B-cell non-Hodgkin lymphoma (iNHL) that has progressed during or within six months of treatment with rituximab… More »
  • MPN Updates

  • January 8, 2014
  • As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research and treatment methods. MPN Updates, a… More »
  • Enhancing Patient and Health Care Team Communications: Paving the way for success
  • Enhancing Patient and Health Care Team Communications: Paving the way for success

  • December 1, 2011
  • Effective communication between health care providers and patients diagnosed with cancer is an essential part of the treatment process. Communicating effectively ensures the patient is an active… More »